# FDA Inspection 1136278 - AstraZeneca Pharmaceuticals LP - February 26, 2021

Source: https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-pharmaceuticals-lp/277a0e01-03e0-435c-a494-2483347396b4/
Source feed: FDA_Inspections

> FDA Inspection 1136278 for AstraZeneca Pharmaceuticals LP on February 26, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1136278
- Company Name: AstraZeneca Pharmaceuticals LP
- Inspection Date: 2021-02-26
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1299436 - 2026-01-14](https://www.globalkeysolutions.net/api/records/fda_inspections/astrazeneca-pharmaceuticals-lp/2c679062-e213-4b23-a225-08c290a553f8/)
- [FDA Inspection 1299436 - 2026-01-14](https://www.globalkeysolutions.net/api/records/fda_inspections/astrazeneca-pharmaceuticals-lp/ed3a47de-819f-4795-ab50-6f8d1648ed45/)
- [FDA Inspection 1254239 - 2024-10-25](https://www.globalkeysolutions.net/api/records/fda_inspections/astrazeneca-pharmaceuticals-lp/da96b405-5d6f-462e-8164-cc589345ae2e/)
- [FDA Inspection 1254239 - 2024-10-25](https://www.globalkeysolutions.net/api/records/fda_inspections/astrazeneca-pharmaceuticals-lp/1041454f-369b-4f69-9160-39d76ce3bdb2/)
- [FDA Inspection 1238346 - 2024-05-31](https://www.globalkeysolutions.net/api/records/fda_inspections/astrazeneca-pharmaceuticals-lp/f4d9b1b5-b5fa-492a-8363-3e39782013b0/)

Company: https://www.globalkeysolutions.net/companies/astrazeneca-pharmaceuticals-lp/f2e34b74-3ef4-4f39-8f6f-41eceb3bb779

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c